Bitemporal visual field defects in ethambutol-induced optic neuropathy

Journal of Neuro-Ophthalmology

Volumn 31, Issue 2, 2011, Pages 121-126

  Kho, Richard C ^a   Al Obailan, Majed ^b   Arnold, Anthony C ^a,c  

^a JULES STEIN EYE INSTITUTE   (United States)

^b American Eye Center   (Philippines)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BITEMPORAL VISUAL FIELD DEFECT; CLINICAL ARTICLE; CONVALESCENCE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC DISK; OPTIC NERVE DISEASE; PERIMETRY; PRIORITY JOURNAL; TREATMENT DURATION; VISUAL ACUITY; VISUAL FIELD DEFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; ETHAMBUTOL; FEMALE; HEMIANOPSIA; HUMANS; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; VISION TESTS; VISUAL FIELD TESTS;

EID: 79958051213     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e318205a148     Document Type: Article

References (26)

1. Carr RE, Henkind P. Ocular manifestations of ethambutol. Arch Ophthalmol. 1962;67:566-571.
2. Asayama T. Two cases of bitemporal hemianopsia due to ethambutol. Jpn J Ophthalmol. 1969;23:1209-1212.
3. Leibold JE. Drugs having a toxic effect on the optic nerve. Int Ophthalmol Clin. 1971;11:137-157.
4. Lessell S. Toxic and deficiency optic neuropathies. In: Smith JL, Glaser JS, eds. Neuro-Ophthalmology, volume 8. St Louis, MO: CV Mosby; 1973:21-37.
5. Bronte-Stewart J, Pettigrew AR, Foulds WS. Toxic optic neuropathy and its experimental production. Trans Ophthalmol Soc U K. 1976;96:355-358. (Pubitemid 8060297)
6. Arruga J. Le test de la ''desaturation'' subjective de la couleur dans le diagnostic de l'atteinte de la voie optiques anterieure par l'ethambutol. Bull Soc Ophtalmol Fr. 1982; 82:189-192.
7. DeVita EG, Miao M, Sadun AA. Optic neuropathy in ethambutol-treated renal tuberculosis. J Clin Neuroophthalmol. 1987;7:77-83. (Pubitemid 18009364)
8. Fledelius HC, Petrera JE, Skjodt K, Trojaborg W. Ocular ethambutol toxicity. Acta Ophthalmol. 1987;65: 251-255.
9. Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1995; 11:411-419.
10. Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1997;13:473-477.
11. Sivakumaran P, Harrison AC, Marschner J, Martin P. Ocular toxicity from ethambutol: a review of four cases and recommended precautions. N Z Med J. 1998;111: 428-430. (Pubitemid 28525361)
12. Melamud A, Kosmorsky GS, Lee MS. Ocular ethambutol toxicity. Mayo Clin Proc. 2003;78:1409-1411. (Pubitemid 37337788)
13. Kocabay G, Erelel M, Tutkin IT, Ecder T. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure. Int J Tuberc Lung Dis. 2006;10:1418-1419. (Pubitemid 44924601)
14. Lim S-A. Ethambutol-associated optic neuropathy. Ann Acad Med Singapore. 2006;35:274-278. (Pubitemid 43954363)
15. Liu Y, Dinkin MJ, Loewenstein JI, Rizzo JF, Cestari DM. Multifocal electroretinographic abnormalities in ethambutol-induced visual loss. J Neuroophthalmol. 2008; 28:278-282.
16. Stewart JF. Automated perimetry and malingerers. Can the Humphrey be outwitted? Ophthalmology. 1995;102: 27-32.
17. Schmidt IG. Central nervous system effects of ethambutol in monkeys. Ann N Y Acad Sci. 1966;135: 759-774.
18. Schmidt IG, Schmidt LH. Studies on the neurotoxicity of ethambutol and its racemate for the rhesus monkey. J Neuropathol Exp Neurol. 1966;25:40-67.
19. Lessell S. Histopathology of experimental ethambutol intoxication. Invest Ophthalmol. 1976;15:765-769.
20. Shiraki H. Neuropathy due to intoxication with antituberculous drugs from neuropathological viewpoint. Adv Neurol Sci. 1973;17:120-125.
21. Lessell S. The histology and histochemistry of the rat's optic nerve and chiasm. Am J Ophthalmol. 1977;84: 681-688. (Pubitemid 8250481)
22. Heng JE, Vorwerk CK, Lessell E, Zurakowski D, Levin LA, Dreyer EB. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. Invest Ophthalmol Vis Sci. 1999; 40:190-196. (Pubitemid 29029588)
23. Zoumalan CI, Sadun AA. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy. Br J Ophthalmol. 2007;91:839-840. (Pubitemid 46846665)
24. Lai TYY, Chan W-M, Lam DSC, Lim E. Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy. Br J Ophthalmol. 2004;88:774-775. (Pubitemid 40780593)
25. Kardon RH, Morrisey MC, Lee AG. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity. Semin Ophthalmol. 2006;21:215-222. (Pubitemid 46005385)
26. Lee EJ, Kim S-J, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008;28:269-277.